Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anwaar Saeed

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
NPJ Precision Oncology|January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapyGaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Journal of Thoracic Disease|May 22, 2025
Construction of a multigenic diagnostic, prognostic, and immune infiltration model with methylation-associated regulators in esophageal squamous cell carcinomaXing Liu, Feng Shen, Ting Wang, et al.
Cancer Medicine|June 16, 2023
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinomaWeijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Molecular Therapy. Oncology|April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancersEmil Lou, Joanne Xiu, Yasmine Baca, et al.
Cell Reports. Medicine|January 26, 2023
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial resultsAnwaar Saeed, Robin Park, Junqiang Dai, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
Annals of Surgical Oncology|November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic AdenocarcinomaAsmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline UpdateManish A Shah, Erin B Kennedy, Dana Deighton, et al.
Plos One|July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
NPJ Precision Oncology|January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapyGaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Journal of Thoracic Disease|May 22, 2025
Construction of a multigenic diagnostic, prognostic, and immune infiltration model with methylation-associated regulators in esophageal squamous cell carcinomaXing Liu, Feng Shen, Ting Wang, et al.
Cancer Medicine|June 16, 2023
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinomaWeijing Sun, Nirmal Veeramachaneni, Raed Al-Rajabi, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Molecular Therapy. Oncology|April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancersEmil Lou, Joanne Xiu, Yasmine Baca, et al.
Cell Reports. Medicine|January 26, 2023
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial resultsAnwaar Saeed, Robin Park, Junqiang Dai, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
Annals of Surgical Oncology|November 4, 2025
KRAS Mutation Allele Frequency Dynamics in Plasma Extracellular Vesicles: Association with Survival in Localized Pancreatic AdenocarcinomaAsmita Chopra, Hong-Zhang He, Jadranka Milosevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline UpdateManish A Shah, Erin B Kennedy, Dana Deighton, et al.
Plos One|July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
Pageof 17